Merit Medical Systems (NASDAQ:MMSI) Lowered to Equal Weight Rating by Wells Fargo & Company

Merit Medical Systems (NASDAQ:MMSI) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a report released on Thursday,Finviz reports. They presently have a $78.00 price objective on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective would indicate a potential downside of 1.55% from the stock’s current price.

A number of other equities research analysts have also recently weighed in on the company. BTIG Research began coverage on Merit Medical Systems in a report on Friday, February 6th. They set a “buy” rating and a $107.00 price target for the company. Barrington Research raised their target price on Merit Medical Systems from $106.00 to $109.00 and gave the company an “outperform” rating in a research note on Wednesday. Zacks Research cut Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Piper Sandler decreased their price objective on shares of Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday, December 29th. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $103.33.

Merit Medical Systems Stock Down 3.9%

Shares of NASDAQ MMSI opened at $79.23 on Thursday. Merit Medical Systems has a 52-week low of $77.62 and a 52-week high of $107.27. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.86 and a current ratio of 4.28. The business has a fifty day moving average of $83.92 and a two-hundred day moving average of $84.94. The stock has a market cap of $4.70 billion, a PE ratio of 37.37, a PEG ratio of 2.24 and a beta of 0.61.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.08. The business had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 14.06%. The firm’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, equities research analysts expect that Merit Medical Systems will post 3.37 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in MMSI. Ameritas Investment Partners Inc. increased its stake in Merit Medical Systems by 2.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,973 shares of the medical instruments supplier’s stock worth $558,000 after purchasing an additional 131 shares in the last quarter. Norden Group LLC lifted its position in Merit Medical Systems by 5.7% in the 3rd quarter. Norden Group LLC now owns 2,536 shares of the medical instruments supplier’s stock valued at $211,000 after acquiring an additional 137 shares in the last quarter. Lido Advisors LLC boosted its stake in Merit Medical Systems by 3.8% in the 4th quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 140 shares during the period. Bryn Mawr Trust Advisors LLC increased its holdings in Merit Medical Systems by 7.2% during the 2nd quarter. Bryn Mawr Trust Advisors LLC now owns 2,225 shares of the medical instruments supplier’s stock worth $208,000 after purchasing an additional 149 shares in the last quarter. Finally, Hilltop National Bank raised its stake in shares of Merit Medical Systems by 8.7% in the 3rd quarter. Hilltop National Bank now owns 2,119 shares of the medical instruments supplier’s stock valued at $176,000 after purchasing an additional 169 shares during the period. Institutional investors and hedge funds own 99.66% of the company’s stock.

More Merit Medical Systems News

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q4 beat — Merit reported $1.04 EPS vs. $0.96 consensus and revenue of $393.9M (vs. $390.8M), with margins expanding and Cardiovascular, U.S. and EMEA sales strong. This fundamental beat supports upside. Article Title
• Positive Sentiment: Raised FY‑2026 guidance — company set EPS guidance of $4.01–$4.15 vs. street ~$3.73, signaling stronger forward earnings potential that underpins valuation. Article Title
• Positive Sentiment: Analyst upgrade — Barrington Research raised its price target to $109 and gave an “outperform” rating, signaling consensus upside from current levels. Article Title
• Neutral Sentiment: Strategic update — Merit projects 6%–8% revenue growth for 2026 while divesting its DualCap business to sharpen focus on global platform strength; this is strategically constructive but will take time to flow to results. Article Title
• Neutral Sentiment: Analyst commentary notes — coverage writeups (TipRanks/Yahoo summaries) emphasize the strong quarter and upbeat outlook even where price targets were adjusted, suggesting analysts remain broadly constructive. Article Title
• Negative Sentiment: Price‑target chop adds volatility — Needham trimmed its PT to $101 from $108 (kept Buy), and mixed analyst PT moves introduce near‑term selling pressure and uncertainty despite fundamentals. Article Title

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.